Weakly supervised detection and classification of basal cell carcinoma using graph-transformer on whole slide images
Commonwealth Dermatology Is First in Massachusetts to Offer Non-Surgical Treatment for Common Skin Cancers
MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
Hedgehog Pathway Inhibitors Market to Expand at a Notable CAGR of ~11.1% Assessment for the Driving Factors, Size, Revenue, Segments, Expansion, Demand, and Opportunities During 2023-2033
Non-melanoma Skin Cancer Market size to grow by USD 180.97 Mn with 36% of the growth to originate from North America – Technavio
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma *SINS): a multicenter, non-inferiority, randomized controlled trial
Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis
Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma
Basaloid follicular hamartomas in pediatric Basal Cell Nevus Syndrome: A diagnostic challenge Click here to view the article on PubMed.gov
Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study
Retrospective analysis of the histopathologic features of basal cell carcinomas in pediatric patients with basal cell nevus syndrome
The use of the photodynamic method in the treatment of recurrent basal cell carcinoma on the example of Gorlin-Goltz syndrome-management algorithm
Treatment of basal cell carcinomas and basaloid follicular hamartomas in basal cell nevus syndrome children and adolescents
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion
Drug holiday approach for Vismodegib treatment in patients with nevoid basal cell carcinoma syndrome: Three cases from real clinical practice
Amenorrhea secondary to vismodegib: An adverse event to consider especially in female patients with Gorlin-Goltz syndrome
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study
Unusual presentation of basal cell carcinoma with fibroepithelioma-like histology in two patients with Gorlin syndrome
A possible chemopreventive role for photodynamic therapy in Gorlin syndrome: a report of basal cell carcinoma reduction and review of literature